254 related articles for article (PubMed ID: 16934536)
1. Treatment of nausea and vomiting: gaps in our knowledge.
Sanger GJ; Andrews PL
Auton Neurosci; 2006 Oct; 129(1-2):3-16. PubMed ID: 16934536
[TBL] [Abstract][Full Text] [Related]
2. Looking beyond 5-HT(3) receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting.
Johnston KD; Lu Z; Rudd JA
Eur J Pharmacol; 2014 Jan; 722():13-25. PubMed ID: 24189639
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.
Zhong W; Shahbaz O; Teskey G; Beever A; Kachour N; Venketaraman V; Darmani NA
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071460
[TBL] [Abstract][Full Text] [Related]
4. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
5. Zingiber officinale (ginger) as an anti-emetic in cancer chemotherapy: a review.
Haniadka R; Rajeev AG; Palatty PL; Arora R; Baliga MS
J Altern Complement Med; 2012 May; 18(5):440-4. PubMed ID: 22540971
[TBL] [Abstract][Full Text] [Related]
6. Nausea and the quest for the perfect anti-emetic.
Andrews PL; Sanger GJ
Eur J Pharmacol; 2014 Jan; 722():108-21. PubMed ID: 24157981
[TBL] [Abstract][Full Text] [Related]
7. Anti-emetics in development.
Loewen PS
Expert Opin Investig Drugs; 2002 Jun; 11(6):801-5. PubMed ID: 12036423
[TBL] [Abstract][Full Text] [Related]
8. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
9. New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations.
Rubenstein EB; Slusher BS; Rojas C; Navari RM
Cancer J; 2006; 12(5):341-7. PubMed ID: 17034670
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the effects of neurokinin
Andrews PLR; Golding JF; Sanger GJ
Br J Clin Pharmacol; 2023 Dec; 89(12):3468-3490. PubMed ID: 37452618
[TBL] [Abstract][Full Text] [Related]
11. Regulation of nausea and vomiting by cannabinoids.
Parker LA; Rock EM; Limebeer CL
Br J Pharmacol; 2011 Aug; 163(7):1411-22. PubMed ID: 21175589
[TBL] [Abstract][Full Text] [Related]
12. Effect of Prophylactic Anti-emetics on Opioid-induced Nausea and Vomiting: A Retrospective Observational Cohort Study.
Tamura T; Kawakado K; Makimoto GO; Nakanishi M; Kuyama S
In Vivo; 2021; 35(3):1737-1742. PubMed ID: 33910857
[TBL] [Abstract][Full Text] [Related]
13. Treating nausea and vomiting in palliative care: a review.
Glare P; Miller J; Nikolova T; Tickoo R
Clin Interv Aging; 2011; 6():243-59. PubMed ID: 21966219
[TBL] [Abstract][Full Text] [Related]
14. Nausea: current knowledge of mechanisms, measurement and clinical impact.
Kenward H; Pelligand L; Savary-Bataille K; Elliott J
Vet J; 2015 Jan; 203(1):36-43. PubMed ID: 25453240
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of postoperative nausea and vomiting.
Kovac AL
Drugs; 2000 Feb; 59(2):213-43. PubMed ID: 10730546
[TBL] [Abstract][Full Text] [Related]
16. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.
Rizk AN; Hesketh PJ
Drugs R D; 1999 Oct; 2(4):229-35. PubMed ID: 10659396
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and management of chemotherapy-induced nausea and vomiting.
Allan SG
Blood Rev; 1987 Mar; 1(1):50-7. PubMed ID: 3332087
[TBL] [Abstract][Full Text] [Related]
18. [Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy].
Yamasaki F; Watanabe Y; Nosaka R; Kenjo M; Nakamura K; Takayasu T; Saito T; Tominaga A; Sugiyama K; Kurisu K
No Shinkei Geka; 2014 Jan; 42(1):27-34. PubMed ID: 24388937
[TBL] [Abstract][Full Text] [Related]
19. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
[TBL] [Abstract][Full Text] [Related]
20. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
Stuart-Harris RC; Mooney CA; Smith IE
Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
